Related Experiment Video

Updated: Sep 26, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Approaches for treatment of liver fibrosis in chronic hepatitis C

Pierre Bedossa1, Valerie Paradis

  • 1Department of Pathology, Service d'anatomie pathologique, Hôpital Bicêtre, Université Paris XI, 78 rue du general Leclerc, 94725 Le Kremlin-Bicêtre, France. pbedossa@teaser.fr

Clinics in Liver Disease
|April 15, 2003
PubMed

Insights

Understanding liver fibrogenesis mechanisms offers antifibrotic targets for Hepatitis C Virus (HCV) infection. Future treatments may reverse fibrosis, but require precise targeting and further research.

Area of Science:

  • Hepatology and Viral Hepatitis Research

Background:

  • Liver fibrogenesis mechanisms have been extensively studied over the last two decades.
  • Fibrogenesis is intrinsically linked to the body's wound healing processes, complicating antifibrotic strategies.
  • Chronic Hepatitis C Virus (HCV) infection leads to liver fibrosis, a significant health concern.

Purpose of the Study:

  • To review potential antifibrotic treatment targets for liver fibrosis in HCV.
  • To discuss the challenges in developing antifibrotic therapies due to the dual role of fibrogenesis in wound healing.
  • To explore future therapeutic goals for chronic HCV infection, including fibrosis reversal.

Main Methods:

  • Literature review of studies on liver fibrogenesis mechanisms.
  • Analysis of potential antifibrotic targets in the context of HCV.
  • Discussion of therapeutic delivery and targeting strategies.

Main Results:

  • Numerous molecular targets for antifibrotic intervention have been identified.
  • The wound healing nature of fibrogenesis presents a significant hurdle for selective antifibrotic drug development.
  • HCV-specific mechanisms may offer more precise therapeutic targets.

Conclusions:

  • Antifibrotic treatments for HCV require selective delivery or targeting of HCV-specific pathways.
  • Reversing existing liver fibrosis is a potential future treatment goal for chronic HCV infection.
  • Substantial research is still needed to translate these findings into clinical reality.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: